Prostate Cancer Screening: Is it Recommended in 2024?

Prostate Cancer Screening: Is it Recommended in 2024?

As we are living the month of Men’s Health awareness, November, we thought of touching base regarding screening for prostate cancer; an intriguing topic indeed, and the jury is out as of yet regarding whether to formalize a screening platform for prostate cancer. The fact remains that prostate ca...

Full description

Saved in:

Bibliographic Details
Main Author:	Dr. Ali Thwaini
Format:	Article
Language:	English
Published:	College of Medicine University of Baghdad 2024-12-01
Series:	مجلة كلية الطب
Subjects:	Prostate Cancer Prostate-Specific Antigen Prospective Studies
Online Access:	https://iqjmc.uobaghdad.edu.iq/index.php/19JFacMedBaghdad36/article/view/3020
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Incidence of prostate adenocarcinoma in transurethral resection of the prostate patients
by: Yahia Ghazwani, et al.
Published: (2025-01-01)

Association between prostate-specific antigen density and prostate cancer prediction among Nigerian men
by: Abudu EK, et al.
Published: (2025-01-01)

A Rare Metastasis of Prostate Cancer
by: İlkin Hamid-Zada, et al.
Published: (2024-07-01)

Potential clinical application of the cancer antigen CA‑62 for differential diagnosis of prostate cancer and benign prostatic hyperplasia at the elevated prostate‑specific antigen
by: Zh. R. Cherkasova, et al.
Published: (2023-03-01)

Influence of Regular Statin Intake on Prostate‐Specific Antigen Values, Prostate Cancer Incidence and Overall Survival in a Prospective Screening Trial (ERSPC Aarau)
by: Alkiviadis Papagiannakis, et al.
Published: (2025-01-01)

Current biomarkers of prostate cancer
by: I. A. Aboian, et al.
Published: (2021-12-01)

Development of novel nomograms for predicting prostate cancer in biopsy-naive patients with PSA < 10 ng/ml and PI-RADS ≤ 3 lesions
by: Jia-gui Chai, et al.
Published: (2025-01-01)

Malondialdehyde in benign prostate hypertrophy: a useful marker?
by: Rosaria Alba Merendino, et al.
Published: (2003-01-01)

Diagnostic Accuracy of Serum Prostate Specific Antigen and Gleason Score in Determining the Presence of Skeletal Metastasis in Prostate Cancer Patients: a Pakistani Perspective
by: Taimoor Nasir, et al.
Published: (2023-04-01)

Liquid Biomarkers in Prostate Cancer Diagnosis: Current Status and Emerging Prospects
by: Yutong Liu, et al.
Published: (2025-01-01)

Value of Systematic and MRI‐Ultrasound Fusion Prostate Biopsy in Different Prostate Specific Antigen (PSA) Levels
by: Solmaz Ohadian Moghadam, et al.
Published: (2025-01-01)

The accuracy of ultrasensitive PSA in predicting disease progression after radical prostatectomy
by: Heikki Seikkula, et al.
Published: (2024-11-01)

High Detection Rates for Prostate-specific Membrane Antigen–avid Prostate Cancer Recurrence at Low Prostate-specific Antigen levels on Extended Axial Field-of-view Positron Emission Tomography/Computed Tomography
by: Sarah Thomas, et al.
Published: (2025-01-01)

Which PSMA PET/CT interpretation criteria most effectively diagnose prostate cancer? a retrospective cohort study
by: Le Ma, et al.
Published: (2025-01-01)

A new ASAP Scoring System and Risk Table to predict second prostate biopsy outcomes
by: Ediz Caner, et al.
Published: (2021-10-01)

Association between visceral adiposity index and prostate cancer in men aged 40 years and older: a nationwide cross-sectional study
by: Wentao Yao, et al.
Published: (2025-12-01)

Dual‐Enhanced SERS Satellite Immuno‐Nanocomplex for Multiple PSA‐Mediated PHI Assay Toward Clinical Prostate Cancer Screening
by: Dong Chen, et al.
Published: (2025-02-01)

Relationship between albumin-globulin ratio and prostate-specific antigen: a cross-sectional study based on NHANES 2003–2010
by: Simeng Gao, et al.
Published: (2025-01-01)

Monitoring of prostate-specific antigen in men with benign prostate enlargement receiving 5-alpha reductase inhibitors: a non-interventional, cross-sectional study of real-world practice of urologists in Spain and Brazil
by: Juan Manuel Palacios, et al.
Published: (2025-01-01)

The factors impacting on Gleason score upgrading in prostate cancer with initial low Gleason scores
by: Tzu-Heng Huang, et al.
Published: (2025-02-01)

The Novel Histological Prostatic Inflammation Score Helps Defining the Association Between Stromal and Glandular Inflammation with the Risk of Prostate Cancer at Prostate Biopsy
by: Ugo Giovanni Falagario, et al.
Published: (2025-01-01)

A case of de novo neuroendocrine prostate cancer presented with elevated level of serum CEA carrying BRCA2 mutation: case report and literature review
by: Weizhe Han, et al.
Published: (2025-01-01)

Urology pathways for the primary care physician
by: J John
Published: (2024-04-01)

Analysis of the predictive value of the prostate-specific antigen-to-neutrophil ratio for the diagnosis of prostate cancer
by: Yuxuan Chen, et al.
Published: (2025-01-01)

Prostate cancer perspective: Africa versus the world
by: B Marais, et al.
Published: (2024-04-01)

The impact of preliminary patient hydration on physiological [18F]PSMA-1007 uptake in the urinary bladder on PET/CT
by: T. L. Antonevskaya, et al.
Published: (2024-06-01)

Transurethral Water Vapor Ablation: Potential for a Novel Prostate Cancer Management Strategy
by: Warlick CA, et al.
Published: (2025-02-01)

Comparison between 18F-DCFPyL PET/MRI-guided ultrasound fusion targeted biopsy and systematic biopsy for tumor detection and grading in selected patients: A prospective randomized controlled trial
by: Shaoxi Niu, et al.
Published: (2025-01-01)

Prostate cancer screening knowledge and attitude among men over 50 at a referral Hospital in Oshana region, Namibia
by: Lonia Kashihakumwa, et al.
Published: (2025-01-01)

Microbially produced imidazole propionate impairs prostate cancer progression through PDZK1
by: Shengkai Jin, et al.
Published: (2025-01-01)

Insights into prostate cancer awareness and perceptions among men in Tshwane
by: L Nzombe, et al.
Published: (2024-06-01)

Advancements in Research on Non-AR- Signaling Pathways and Targeted Therapies for Castration-Resistant Prostate Cancer
by: Haq Dad, et al.
Published: (2025-01-01)

Metabolomic profile and its association with the diagnosis of prostate cancer: a systematic review
by: Angela Patricia Salinas Pita, et al.
Published: (2024-12-01)

Correlation of clinically significant prostate cancer sites across multiparametric MRI, prostate biopsy, and whole-mount pathology for optimal prostate biopsy strategy
by: Matteo Pacini, et al.
Published: (2025-02-01)

Focal Therapy for Prostate Cancer: Recent Advances and Insights
by: Francesco Lasorsa, et al.
Published: (2024-12-01)

Comparison of Finasteride and Dutasteride on Risk of Prostate Cancer in Patients with Benign Prostatic Hyperplasia: A Pooled Analysis of 15 Real-world Databases
by: Dae Yul Yang, et al.
Published: (2025-01-01)

A Systematic Review of the Association between Psychological Resilience and Improved Psychosocial Outcomes in Prostate Cancer Patients: Could Resilience Training Have a Potential Role?
by: David Robert Harry Christie, et al.
Published: (2025-01-01)

The association between the interval from biopsy to radical prostatectomy and biochemical recurrence in patients with intermediate- and high-risk prostate cancer
by: Carolin Siech, et al.
Published: (2025-02-01)

The Role of Immunohistochemistry for AMACR/p504s and p63 in Distinguishing Prostate Cancer from Benign Prostate Tissue Samples in Botswana
by: Ramatlho P, et al.
Published: (2025-01-01)

Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer
by: Arjun Pon Avudaiappan, et al.
Published: (2024-11-01)